INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
PATIENT REVENUES, NET	$ 118,243	$ 117,967	$ 238,230	$ 235,517
OTHER OPERATING INCOME	5,148	0	5,148	0
EXPENSES:
Operating	95,775	94,658	190,634	189,080
Lease and rent expense	13,523	13,114	27,036	26,229
Professional liability	2,114	1,594	3,953	3,445
Government settlement expense	0	3,100	0	3,100
General and administrative	6,880	7,152	13,638	14,365
Depreciation and amortization	2,278	2,217	4,565	4,533
Total expenses	120,570	121,835	239,826	240,752
OPERATING INCOME (LOSS)	2,821	(3,868)	3,552	(5,235)
OTHER INCOME (EXPENSE):
Other income	409	40	524	200
Interest expense, net	(1,209)	(1,476)	(2,669)	(2,870)
Total other expense	(800)	(1,436)	(2,145)	(2,670)
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	2,021	(5,304)	1,407	(7,905)
PROVISION FOR INCOME TAXES	(182)	(17,312)	(78)	(16,285)
INCOME (LOSS) FROM CONTINUING OPERATIONS	1,839	(22,616)	1,329	(24,190)
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax benefit of $167 and $111, respectively	(387)	(1,980)	(630)	(3,752)
NET INCOME (LOSS)	$ 1,452	$ (24,596)	$ 699	$ (27,942)
Per common share – basic
Continuing operations (in dollars per share)	$ 0.28	$ (3.49)	$ 0.21	$ (3.75)
Discontinued operations (in dollars per share)	(0.06)	(0.31)	(0.10)	(0.58)
Net loss per common share – basic (dollars per share)	0.22	(3.80)	0.11	(4.33)
Per common share – diluted
Continuing operations (in dollars per share)	0.28	(3.49)	0.21	(3.75)
Discontinued operations (in dollars per share)	(0.06)	(0.31)	(0.10)	(0.58)
Net income (loss) per common share – diluted (dollars per share)	$ 0.22	$ (3.80)	$ 0.11	$ (4.33)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (shares)	6,649	6,472	6,506	6,448
Diluted (shares)	6,704	6,472	6,586	6,448